Related Experiment Video
Updated: Jul 4, 2025
Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
Published on: August 4, 2021
Integration of the Molecular Classification of Endometrial Carcinoma to Select Patients for Fertility Sparing
Mohamed Amine Bani1,2, Amandine Maulard3, Philippe Morice3,4
1Medical Biology and Pathology Department, Morphological Pathology Laboratory, Gustave Roussy Cancer Campus, Villejuif, France; Mohamed-Amine.BANI@gustaveroussy.fr.
Abstract:
Fertility-sparing treatment (FST) for endometrial carcinoma (EC) is an option for a subgroup of young women with low-risk disease. The low-risk group comprises patients with endometrioid EC stage IA, grade 1, with or without focal lymphovascular invasion. In the era of molecular subtyping, treatment de-escalation for some EC subtypes is recommended. Recommendations for fertility-preserving treatments were developed regardless of the molecular classification of EC. However, few studies have focused on this topic. In this review, we summarize the actual data available in the literature and discuss the impact of some molecular subtypes of FST.
More Related Videos
07:46Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
Published on: October 13, 2023
11:29Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
Published on: January 22, 2022